(s, 3H); 13C NMR (CDCl3) d 158.8, 147.3, 131.3, 128.8 (2C),
126.5, 126.2, 122.2, 119.4, 119.0, 114.2 (2C), 113.1, 109.5, 79.7,
55.2, 40.8, 32.8.
7.35–7.20 (m, 7H), 7.09 (td, J = 7.2, 1.2 Hz, 1H), 6.93 (s, 1H),
6.03–5.93 (m, 1H), 5.23–5.18 (m, 2H), 5.17–5.04 (m, 2H), 4.95
(dd, J = 12.4, 8.8 Hz, 1H), 4.70–4.68 (m, 2H); 13C NMR (CDCl3)
d 139.2, 136.7, 133.1, 128.9 (2C), 127.7 (2C), 127.5, 126.7, 125.2,
122.2, 119.6, 119.1, 117.5, 113.1, 109.9, 79.5, 48.8, 41.5. HRMS
C19H18N2O2 [M + Na]+ calculated 329.1266; found 329.1265.
3-(1-Furan-2-yl-2-nitroethyl)-1-methyl-1H-indole (3e). The
ee was determined by HPLC using a Daicel Chiralcel AS column
(hexane–2-propanol = 95 : 5, flow rate 1.0 mL min−1, smajor
=
34.2 min; sminor = 38.6 min). [a]rDt = −16.8 (c = 2.0 g per 100 mL,
CHCl3, 40% ee); 1H NMR (CDCl3) d 7.51 (d, J = 8.4 Hz, 1H),
7.34 (d, J = 1.6 Hz, 1H), 7.27 (d, J = 8.4 Hz, 1H), 7.21 (td,
J = 7.6, 1.2 Hz, 1H), 7.09 (td, J = 7.6, 0.8 Hz, 1H), 6.94 (s,
1H), 6.27 (dd, J = 3.2, 2.0 Hz, 1H), 6.13 (d, J = 3.2 Hz, 1H),
5.19 (t, J = 8.0 Hz, 1H), 5.00 (dd, J = 12.4, 8.4 Hz, 1H), 4.86
(dd, J = 12.8, 7.2 Hz, 1H), 3.71 (s, 3H); 13C NMR (CDCl3)
d 152.3, 142.2, 137.1, 127.3, 126.1, 122.1, 119.5, 118.8, 110.4,
109.9, 109.6, 107.2, 77.9, 35.6, 32.8. HRMS C15H14N2O3 [M +
Na]+ calculated 293.0902; found 293.0915.
1-Benzyl-3-(2-nitro-1-phenylethyl)-1H-indole (3k). The ee
was determined by HPLC using a Daicel Chiralcel AS column
(hexane–2-propanol = 95 : 5, flow rate 1.0 mL min−1, sminor
=
15.1 min; smajor = 17.7 min). [a]rDt = +4.9 (c = 1.9 g per 100 mL,
CHCl3, 13% ee); 1H NMR (CDCl3) d 7.47 (d, J = 7.6 Hz, 1H),
7.37–7.25 (m, 10H), 7.18 (t, J = 8.0 Hz, 1H), 7.08 (t, J = 7.2 Hz,
2H), 6.99 (s, 1H), 5.29 (s, 2H), 5.22 (t, J = 8.0 Hz, 1H), 5.07
(dd, J = 12.4, 7.6 Hz, 1H), 4.95 (dd, J = 12.4, 8.4 Hz, 1H);
13C NMR (CDCl3) d 139.2, 137.1, 136.8, 128.8 (2C), 128.7 (2C),
127.7 (2C), 127.6, 127.5, 126.7, 126.6 (2C), 125.6, 122.4, 119.6,
119.1, 113.4, 110.0, 79.5, 50.0, 41.5. HRMS C23H20N2O2 [M +
Na]+ calculated 379.1422; found 379.1427.
1-Methyl-3-(2-nitro-1-thiophen-2-ylethyl)-1H-indole
(3f).
The ee was determined by HPLC using a Daicel Chiralcel AS
column (hexane–2-propanol = 95 : 5, flow rate 1.0 mL min−1,
smajor = 43.5 min; sminor = 51.2 min). [a]rDt = +5.2 (c = 1.8 g per
5-Methoxy-1-methyl-3-(2-nitro-1-phenylethyl)-1H-indole (3l).
The ee was determined by HPLC using a Daicel Chiralcel AS
column (hexane–2-propanol = 99 : 1, flow rate 1.0 mL min−1,
sminor = 63.7 min; smajor = 68.8 min). [a]rDt = −12.3 (c = 1.7 g per
1
100 mL, CHCl3, 43% ee); H NMR (CDCl3) d 7.51 (d, J =
7.6 Hz, 1H), 7.30 (d, J = 8.0 Hz, 1H), 7.24 (t, J = 8.0 Hz, 1H),
7.19 (dd, J = 4.8, 1.2 Hz, 1H), 7.10 (td, J = 4.0, 1.2 Hz, 1H),
6.99–6.93 (m, 3H), 5.44 (t, J = 8.0 Hz, 1H), 5.05–4.94 (m, 2H),
3.76 (s, 3H); 13C NMR (CDCl3) d 143.1, 139.2, 126.9, 126.6,
126.1, 125.1, 124.8, 122.3, 119.6, 118.9, 112.4, 109.6, 80.1, 36.9,
32.9. HRMS C15H14N2O2S [M + Na]+ calculated 309.0674;
found 309.0684.
1
100 mL, CHCl3, 63% ee); H NMR (CDCl3) d 7.36–7.28 (m,
5H), 7.20 (d, J = 8.8 Hz, 1H), 6.93–6.89 (m, 2H), 6.85 (s, 1H),
5.16 (t, J = 8.0 Hz, 1H), 5.04 (dd, J = 12.4, 8.0 Hz, 1H), 4.93
(dd, J = 12.4, 8.0 Hz, 1H), 3.80 (s, 3H), 3.70 (s, 3H); 13C NMR
(CDCl3) d 153.9, 139.3, 132.6, 128.9 (2C), 127.7 (2C), 127.5,
126.8 (2C), 112.2, 112.1, 110.3, 100.8, 79.4, 55.8, 41.4, 33.0.
3-(1-Cyclohexyl-2-nitroethyl)-1-methyl-1H-indole (3g). The
6-Chloro-1-methyl-3-(2-nitro-1-phenylethyl)-1H-indole (3m).
The ee was determined by HPLC using a Daicel Chiralcel AS
column (hexane–2-propanol = 99 : 1, flow rate 1.0 mL min−1,
sminor = 77.6 min; smajor = 82.8 min). [a]rDt = +2.5 (c = 1.0 g per
ee was determined by HPLC using a Daicel Chiralcel AS column
(hexane–2-propanol = 99 : 1, flow rate 1.0 mL min−1, smajor
=
32.6 min; sminor = 37.4 min). [a]rDt = −4.5 (c = 1.4 g per 100 mL,
CHCl3, 11% ee); 1H NMR (CDCl3) d 7.61 (d, J = 7.6 Hz, 1H),
7.31 (d, J = 7.6 Hz, 1H), 7.25 (t, J = 7.6 Hz, 1H), 7.14 (t, J =
7.6 Hz, 1H), 6.86 (s, 1H), 4.81 (dd, J = 8.0, 6.4 Hz, 1H), 4.72
(dd, J = 12.0, 9.6 Hz, 1H), 3.75 (s, 3H), 3.69 (m, 1H), 1.87–
1.63 (m, 6H), 1.32–0.99 (m, 5H); 13C NMR (CDCl3) d 136.9,
127.3, 126.8, 121.7, 119.1, 119.0, 111.5, 109.4, 78.5, 41.7, 40.4,
32.7, 31.4, 30.3, 26.2, 26.1, 26.1. HRMS C17H22N2O2 [M + Na]+
calculated 309.1579; found 309.1585.
1
100 mL, CHCl3, 40% ee); H NMR (CDCl3) d 7.35–7.26 (m,
7H), 7.02 (dd, J = 8.4, 1.2 Hz, 1H), 6.89 (s, 1H), 5.14 (t, J =
8.0 Hz, 1H), 5.01 (dd, J = 12.4, 8.0 Hz, 1H), 4.91 (dd, J = 12.4,
8.0 Hz, 1H), 3.71 (s, 3H); 13C NMR (CDCl3) d 139.0, 137.6,
129.0 (2C), 128.2, 127.6 (2C), 126.8, 125.1, 120.1, 119.9 (2C),
113.0, 109.5, 79.4, 41.3, 32.9.
2 - ( 1 - Methyl - 1H - indol - 3 - yl ) - 2 - phenylethylamine ( 5a ).
0.39 mmol of optically pure 3a was dissolved in 10 mL MeOH
then 148 mg NH4CO2H and 70 mg Pd/C was added and the
mixture was stirred for 6 h at 60 ◦C. After filtered Pd/C, MeOH
was removed in vacuo and 5a was obtained without further
1-Methyl-3-(1-nitromethylhexyl)-1H-indole (3h). The ee was
determined by HPLC using a Daicel Chiralcel AS column
(hexane–2-propanol = 99 : 1, flow rate 1.0 mL min−1, smajor
=
17.6 min; sminor = 19.8 min). [a]rDt = −5.0 (c = 1.5 g per 100 mL,
CHCl3, 19% ee); 1H NMR (CDCl3) d 7.53 (d, J = 8.0 Hz, 1H),
7.22 (d, J = 8.0 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.04 (t,
J = 7.6 Hz, 1H), 6.80 (s, 1H), 4.59–4.49 (m, 2H), 3.72–3.62
(m, 1H), 3.65 (s, 3H), 1.80–1.63 (m, 2H), 1.18 (m, 5H), 0.78–
0.73 (m, 4H); 13C NMR (CDCl3) d 136.9, 137.2, 126.5, 121.8,
119.1, 118.8, 112.4, 109.5, 80.7, 36.2, 32.7, 32.4, 31.6, 26.8, 22.4,
14.0. HRMS C17H22N2O2 [M + Na]+ calculated 297.1579; found
297.1583.
1
purification. H NMR (CDCl3) d 7.39 (d, J = 8.0 Hz, 1H),
7.27–7.10 (m, 7H), 7.10 (t, J = 7.6 Hz, 1H), 6.82 (s, 1H), 4.17
(t, J = 7.2 Hz, 1H), 3.68 (s, 3H), 3.34 (dd, J = 12.4, 7.2 Hz,
1H), 3.20 (dd, J = 12.4, 7.6 Hz, 1H), 1.50 (s, br, 2H); 13C NMR
(CDCl3) d 143.1, 137.2, 128.5, 128.1, 127.4, 126.3, 126.0, 121.7,
119.4, 118.8, 116.1, 109.2, 47.4, 46.9, 32.7. HRMS C17H18N2
[M + H]+ calculated 251.1548; found 251.1537.
[2-(1-Methyl-1H-indol-3-yl)-2-phenylethyl]carbamic acid methyl
ester (6). Compound 5a was dissolved in a mixture of CH2Cl2
and saturated Na2CO3 solution (1 : 1, 10 mL) and 1.17 mmol
methyl chlorofomate was added. The reaction mixture was
stirred at room temperature for 24 h and extracted by CH2Cl2,
dried by Na2SO4. The solvent was removed in vacuo. The residue
was purified by FC (20% Et2O–petane) to obtain 6 in 92% yield
based on 3a. The ee of 6 was determined by HPLC using a
Daicel Chiralcel AS column (hexane–2-propanol = 97 : 3, flow
+11.0 (c = 1.0 g per 100 mL, CHCl3, 96% ee); 1H NMR (CDCl3)
d 7.51 (d, J = 8.0 Hz, 1H), 7.35–7.21 (m, 7H), 7.06 (t, J = 8.0 Hz,
1H), 6.88 (s, 1H), 4.78 (s br, 1H), 4.44 (t, J = 8.0 Hz, 1H), 4.00
(m, 1H), 3.80–3.70 (m, 1H), 3.76 (s, 3H), 3.65 (s, 3H); 13C NMR
(CDCl3) d 156.9, 142.1, 137.2, 128.6 (2C), 128.0 (2C), 127.2,
126.7, 126.3, 121.8, 119.5, 119.0, 115.1, 109.2, 52.0, 45.7, 43.1,
3-(2-Nitro-1-phenylethyl)-1H-indole (3i). The ee was deter-
mined by HPLC using a Daicel Chiralcel AD column (hexane–
2-propanol = 90 : 10, flow rate 1.0 mL min−1, sminor = 23.4 min;
smajor = 25.4 min). [a]Drt = +0.8 (c = 2.0 g per 100 mL, CHCl3,
11% ee); 1H NMR (CDCl3) d 8.05 (s br, 1H), 7.41 (d, J = 8.0 Hz,
1H), 7.32–7.14 (m, 7H), 7.04 (td, J = 7.6, 1.2 Hz, 1H), 6.97 (d,
J = 2.4 Hz, 1H), 5.15 (t, J = 8.0 Hz, 1H), 5.04 (dd, J = 12.4,
8.0 Hz, 1H), 4.90 (dd, J = 12.4, 8.0 Hz, 1H); 13C NMR (CDCl3)
d 139.1, 136.4, 129.0, 128.9, 127.7, 127.5, 127.0, 126.1, 122.7,
121.6, 119.9, 118.9, 114.4, 111.4, 79.5, 41.5.
rate 1.0 mL min−1, sminor = 27.4 min; smajor = 32.0 min). [a]rDt
=
1-Allyl-3-(2-nitro-1-phenylethyl)-1H-indole (3j). The ee was
determined by HPLC using a Daicel Chiralcel AD column
(hexane–2-propanol = 95 : 5, flow rate 1.0 mL min−1, sminor
=
9.3 min; smajor = 11.8 min). [a]rDt = +7.8 (c = 0.9 g per 100 mL,
CHCl3, 36% ee); 1H NMR (CDCl3) d 7.46 (d, J = 8.4 Hz, 1H),
2 5 7 0
O r g . B i o m o l . C h e m . , 2 0 0 5 , 3 , 2 5 6 6 – 2 5 7 1